文献速递慢病管理预防保健、筛查与疫苗

REVERSE研究:高血压前期自我监测血压的可行性

How feasible is self-monitoring for the management of prehypertension? The REVERSE study.
PubMed 文献 · Br J Gen Pract · 2026-05-14

该前瞻性、非随机、混合方法可行性研究在英格兰兰开夏郡和南坎布里亚郡基层医疗中招募高血压前期(血压120-139/80-89 mmHg)患者,训练其每月前3天自测血压并坚持6个月。80名合格参与者中83%完成6个月随访、41%完成12个月随访,无不良事件,疾病感知评分显著下降,提示该方案在全科实践中可行但需进一步验证。

要点

  • 高血压前期患者经培训后每月自测血压3天、持续6个月的方案在基层可行且无不良事件。
  • 研究显示疾病感知评分显著下降(从均值26.6降至22.6,p=0.002),其他指标无显著变化。
  • 样本以全科诊所招募为主、种族和社会经济多样性有限,推广至药房和社区需进一步探索。

核心结论

  • 高血压前期血压自我监测在全科实践中可行,但需在药房和社区提供者中进一步探索。
  • 上述发现需在有效性试验中加以确认。

研究设计与样本

  • 前瞻性、非随机、混合方法可行性研究,在英格兰兰开夏郡和南坎布里亚郡的基层医疗中开展。
  • 从5家全科诊所、3家药房和1家血压检测提供者处招募高血压前期患者。
  • 参与者接受血压计和培训,在6个月内每月前3天自我监测血压并向研究团队提交结果。
  • 在基线、6个月和12个月收集结局数据,主要采用描述性统计分析。

主要发现

  • 162人表达兴趣,80人符合条件并知情同意,其中78人来自全科诊所,药房和社区提供者各1人。
  • 66人(83%)完成6个月随访,33人(41%)完成12个月随访,缺失数据很少。
  • 未报告不良事件。
  • 疾病感知评分显著下降(均值26.6[SD 8.6]降至均值22.6[SD 8.7],p=0.002),其他指标无显著变化。
  • 仅1名非白人参与者,社会经济多样性有限,限制了推广性并提示需针对性外展。

临床怎么用

  • 全科医生可考虑对高血压前期患者提供血压计和培训,实施每月前3天自测血压的方案。
  • 实施中需关注招募多样性,针对少数族裔和社会经济弱势群体开展针对性外展。
  • 该方案在药房和社区提供者中的可行性尚需进一步探索,暂不宜广泛推广。

局限性

  • 非随机设计,无法确定自我监测对临床结局的因果效应。
  • 12个月随访完成率仅41%,存在失访偏倚风险。
  • 仅1名非白人参与者且社会经济多样性有限,结果外推性受限。
  • 主要来自全科诊所招募,药房和社区提供者样本极少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prehypertension (blood pressure (BP) 120-139/80-89 mmHg) affects 40% of UK adults increasing cardiovascular risk. While BP self-monitoring is effective in hypertension, its feasibility in prehypertension is unclear. Concerns include lack of interest, medicalisation, and unintended consequences, despite evidence suggesting it may empower individuals in risk management and prevention. AIM: To determine the feasibility of BP self-monitoring for prehypertension. METHOD: A prospective, non-randomised, mixed-methods, feasibility study across primary care in Lancashire and South Cumbria. People with prehypertension were recruited from five general practices, three pharmacies, and one BP-checking provider. Participants received a BP monitor and training, then self-monitored BP on the first 3 days of each month for 6 months. Participants submitted their results to the research team. Outcome data were collected at baseline, 6-months, and 12-months and analysed mainly using descriptive statistics. RESULTS: Of 162 expressions of interest, 80 were eligible and consented; 78 from general practice, one each from pharmacy and community providers. Of those recruited, 66 (83%) and 33 (41%) completed 6-month and 12-month follow-up, respectively, with minimal missing data. No adverse effects were reported. Illness perception scores significantly decreased (mean 26.6 [SD 8.6] to mean 22.6 [SD 8.7], p=0.002), with no other significant changes. There was only one non-White participant, and limited socioeconomic diversity, limiting generalisability and highlighting the need for targeted outreach. CONCLUSION: BP self-monitoring for prehypertension is feasible in general practice, but requires further exploration with pharmacy, and community providers. These findings need confirming in an effectiveness trial.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Bray E, Hives L, Georgiou R, et al. How feasible is self-monitoring for the management of prehypertension? The REVERSE study. Br J Gen Pract. 2026. PMID: 42134915. doi:10.3399/bjgp26X745041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。